ArticleJournal of neuro-oncology2026
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study.
Sinem Akbas et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2026
this papercites it